Results 111 to 120 of about 16,252 (181)

Low-dose erythropoietin in anemic arthroplasty patients within contemporary patient blood management pathways. [PDF]

J Orthop Surg Res
Hourlier H, Fricault G, Fennema P.
europepmc   +1 more source

Reverse-normal immunopurification: An effective approach for purifying recombinant erythropoietin from its analogues in doping analysis. [PDF]

J Sport Health Sci
He S, Wu D, Niu C, Liu X, Zhang J, Xie L, Martin L, Liu K, Zhou X, Zhang L.   +9 more
europepmc   +1 more source

Evaluating Transcriptomic Biomarkers for rHuEPO Detection: Assessing the Impact of Exercise and Altitude Exposure. [PDF]

Drug Test Anal
Obratov D, Sutehall S, Liu L, Zhongying Z, Pitsiladis Y.   +4 more
europepmc   +1 more source

Specialty grand challenge: existing issues and emerging frontiers in renal endocrinology. [PDF]

Front Endocrinol (Lausanne)
Haque ATME, Razzaque MS.
europepmc   +1 more source

Management of autoimmune hemolytic anemia. [PDF]

Hematology Am Soc Hematol Educ Program
Barcellini W, Fattizzo B.
europepmc   +1 more source

Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study. [PDF]

Front Pharmacol
Liu L, Lin M, Yang W, Yao D, Luo H, Yu L, Dai H.   +6 more
europepmc   +1 more source

Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation. [PDF]

Am J Hematol
Lanikova L, Hrckulak D, Zimolova V, Lorenzo FR, Song J, Vecerkova K, Babosova O, Berkova L, Korinek V, Elliott S, Prchal JT.   +10 more
europepmc   +1 more source

Breaking the noninflamed barrier: tumor-secreted erythropoietin as a master regulator of immunosuppressive macrophages. [PDF]

J Natl Cancer Cent
Wang X, Tao Y, Zhou J, Zhang J, Ding G.
europepmc   +1 more source

Efficacy and safety of high and low dose recombinant human erythropoietin on neurodevelopment of premature infants: A meta-analysis: Retraction. [PDF]

Medicine (Baltimore)
europepmc   +1 more source

Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome. [PDF]

Ann Hematol
Gao Z, Yang F, Pan H, Zhang L, Li W, Li R, Zhao J, Luo Y, Yu X, Kuang Z, Nie N, Li J, Huang J, Zhao X, Ge M, Zheng Y, Fang L, Shi J.   +17 more
europepmc   +1 more source